Douwe Atsma
Professor Cardiology, in particular innovative cardiovascular concepts of care
- Name
- Prof.dr. D.E. Atsma
- Telephone
- +31 70 526 2020
- d.e.atsma@lumc.nl
Professor Cardiology, in particular innovative cardiovascular concepts of care
- Faculteit Geneeskunde
- LUMC - Medische Faculteit Leiden
- Divisie 1
- Hartziekten
- Albalak, G.; Stijntjes, M.; Bodegom, D. van; Jukema, J.W.; Atsma, D.E.; Heemst, D. van & Noordam, R. (2022), Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general population, European Journal of Preventive Cardiology.
- Dirikgil, E.; Brons, K.; Duindam, M.; Groeneveld, G.H.; Geelhoed, J.J.M.; Heringhaus, C.; Boog, P.J.M. van der; Rabelink, T.J.; Bos, W.J.W.; Chavannes, N.H.; Atsma, D.E. & Teng, Y.K.O. (2022), COVID-box Experiences of Patients and Health Care Professionals (COVID-box Project): Single-Center, Retrospective, Observational Study, JMIR Formative Research 6(7).
- Gorp, P.R.R. van; Zhang, J.; Liu, J.; Tsonaka, R.; Mei, H.; Dekker, S.O.; Bart, C.I.; Coster, T. de; Post, H.; Heck, A.J.R.; Schalij, M.J.; Atsma, D.E.; Pijnappels, D.A. & Vries, A.A.F. de (2022), Sbk2, a Newly Discovered Atrium-Enriched Regulator of Sarcomere Integrity, Circulation Research 131(1): 24-41.
- Treskes, R.W.; Akker-van Marle, M.E. van den; Winden, L. van; Keulen, N. van; Velde, E.T. van der; Beeres, S.; Atsma, D. & Schalij, M.J. (2022), The Box-eHealth in the Outpatient Clinic Follow-up of Patients With Acute Myocardial Infarction: Cost-Utility Analysis, Journal of Medical Internet Research 24(4).
- Hattem, N.E. van; Beeres, S.L.M.A.; Mertens, B.J.A.; Antoni, M.L.; Atsma, D.E.; Schalij, M.J. & Haan, M.C. den (2022), Emergency heart failure mortality risk grade may help to reduce heart failure admissions, Netherlands Heart Journal.
- Silven, A.V.; Peet, P.G. van; Boers, S.N.; Tabak, M.; Groot, A. de; Hendriks, D.; Os, H.J.A. van; Bonten, T.N.; Atsma, D.E.; Graaf, T.J. de; Sombroek, M.P.; Chavannes, N.H. & Villalobos-Quesada, M. (2022), Clarifying responsibility: professional digital health in the doctor-patient relationship, recommendations for physicians based on a multi-stakeholder dialogue in the Netherlands, BMC Health Services Research 22(1).
- Rodrigues, T.R.C.; Buisonje, D.R. de; Keesman, M.; Reijnders, T.; Geer, J.E. van der; Janssen, V.R.; Kraaijenhagen, R.A.; Atsma, D.E. & Evers, A.W.M. (2021), Facilitators of and barriers to lifestyle support and eHealth solutions, Journal of Medical Internet Research 23(10).
- Dirikgil, E.; Roos, R.; Groeneveld, G.H.; Heringhaus, C.; Silven, A.V.; Petrus, A.H.J.; Villalobos-Quesada, M.; Tsonaka, R.; Boog, P.J.M.V.; Rabelink, T.J.; Bos, W.J.W.; Chavannes, N.H.; Atsma, D.E. & Teng, Y.K.O. (2021), Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project.
- Pluijmert, N.J.; Jong, R.C.M. de; Vries, M.R. de; Pettersson, K.; Atsma, D.E.; Jukema, J.W. & Quax, P.H.A. (2021), Phosphorylcholine antibodies restrict infarct size and left ventricular remodelling by attenuating the unreperfused post-ischaemic inflammatory response, Journal of Cellular and Molecular Medicine 25(16).
- Burgt, A. van de; Dibbets-Schneider, P.; Slump, C.H.; Scholte, A.J.H.A.; Atsma, D.E.; Geus-Oei, L.F. de & Velden, F.H.P. van (2021), Experimental validation of absolute SPECT/CT quantification for response monitoring in patients with coronary artery disease, EJNMMI Physics 8(1).
- Povsic, T.J.; Sanz-Ruiz, R.; Climent, A.M.; Bolli, R.; Taylor, D.A.; Gersh, B.J.; Menasche, P.; Perin, E.C.; Pompilio, G.; Atsma, D.E.; Badimon, L.; DeMaria, A.N.; Hare, J.M.; Henry, T.D.; Janssens, S.; Kastrup, J.; Torella, D.; Traverse, J.H.; Willerson, J.T. & Fernandez-Aviles, F. (2021), Reparative cell therapy for the heart, ESC Heart Failure 8(3): 2306-2309.
- Breeman, L.D.; Keesman, M.; Atsma, D.E.; Chavannes, N.H.; Janssen, V.; Gemert-Pijnen, L. van; Kemps, H.; Kraaij, W.; Rauwers, F.; Reijnders, T.; Reimer, W.S.O.; Wentzel, J.; Kraaijenhagen, R.A.; Evers, A.W.M. & BENEFIT Consortium (2021), A multi-stakeholder approach to eHealth development, International Journal of Medical Informatics 147.
- Pluijmert, N.J.; Jong, R.C.M. de; Vries, M.R. de; Pettersson, K.; Atsma, D.E.; Jukema, J.W. & Quax, P.H.A. (2020), Phosphorylcholine antibodies preserve cardiac function and reduce infarct size by attenuating the post-ischemic inflammatory response, JACC: Basic to Translational Science 5(12): 1228-1239.
- Frel, D.L. de; Atsma, D.E.; Pijl, H.; Seidell, J.C.; Leenen, P.J.M.; Dik, W.A. & Rossum, E.F.C. van (2020), The impact of obesity and lifestyle on the immune system and susceptibility to infections such as COVID-19, Frontiers in Nutrition 7.
- Pluijmert, N.J.; Bart, C.I.; Bax, W.H.; Quax, P.H.A. & Atsma, D.E. (2020), Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice, Scientific Reports 10(1).
- Pluijmert, N.J.; Bart, C.I.; Bax, W.H.; Quax, P.H.A. & Atsma, D.E. (2020), Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice, Scientific Reports 10(1).
- Silven, A.V.; Petrus, A.H.J.; Villalobos-Quesada, M.; Dirikgil, E.; Oerlemans, C.R.; Landstra, C.P.; Boosman, H.; Os, H.J.A. van; Blanker, M.H.; Treskes, R.W.; Bonten, T.N.; Chavannes, N.H.; Atsma, D.E. & Teng, Y.K.O. (2020), Telemonitoring for patients with COVID-19, Journal of Medical Internet Research 22(9).
- Treskes, R.W.; Winden, L.A.M. van; Keulen, N. van; Velde, E.T. van der; Beeres, S.L.M.A.; Atsma, D.E. & Schalij, M.J. (2020), Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction a randomized clinical trial, Jama Network Open 3(4).
- Pluijmert, N.J.; Haan, M.C. den; Zuylen, V.L. van; Steendijk, P.; Boer, H.C. de; Zonneveld, A.J. van; Fibbe, W.E.; Schalij, M.J.; Quax, P.H.A. & Atsma, D.E. (2019), Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury, PLoS ONE 14(6).
- Keesman, M.; Janssen, V.; Kemps, H.; Hollander, M.; Reimer, W.S.O.; Gemert-Pijnen, L. van; Hoes, A.; Kraaij, W.; Chavannes, N.; Atsma, D.; Kraaijenhagen, R.; Evers, A. & BENEFIT Consortium (2019), BENEFIT for all: An ecosystem to facilitate sustained healthy living and reduce the burden of cardiovascular disease, European Journal of Preventive Cardiology 26(6): 606-608.
- Mann, I.; Tseng, C.C.S.; Rodrigo, S.F.; Koudstaal, S.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Geus-Oei, L.F. de; Lamb, H.J.; Wolterbeek, R.; Zwaginga, J.J.; Fibbe, W.E.; Westinga, K.; Bax, J.J.; Doevendans, P.A.; Schalij, M.J.; Chamuleau, S.A.J. & Atsma, D.E. (2019), Intramyocardial bone marrow cell injection does not lead to functional improvement in patients with chronic ischaemic heart failure without considerable ischaemia, Netherlands Heart Journal 27(2): 81-92.
- Jong, R.C.M. de; Pluijmert, N.J.; Vries, M.R. de; Pettersson, K.; Atsma, D.E.; Jukema, J.W. & Quax, P.H.A. (2018), Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response., Scientific Reports 8(1).
- Jong, R.C.M. de; Pluijmert, N.J.; Vries, M.R. de; Pettersson, K.; Atsma, D.E.; Jukema, J.W. & Quax, P.H.A. (2018), Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response, Scientific Reports 8.
- Rodrigo, S.F.; Mann, I.; Ramshorst, J. van; Beeres, S.L.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2017), Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results, Journal of Interventional Cardiology 30(5): 440-447.
- Treskes, R.W.; Winden, L.A. van; Keulen, N. van; Atsma, D.E.; Velde, E.T. van der; Akker-van Marle, E. van den; Mertens, B. & Schalij, M.J. (2017), Using Smart Technology to Improve Outcomes in Myocardial Infarction Patients: Rationale and Design of a Protocol for a Randomized Controlled Trial, The Box, JMIR Research Protocols 6(9).
- Brandao, K.O.; Tabel, V.A.; Atsma, D.E.; Mummery, C.L. & Davis, R.P. (2017), Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies, Disease Models and Mechanisms 10(9): 1039-1059.
- Hiemstra, Y.L.; Debonnaire, P.; Bootsma, M.; Zwet, E.W. van; Delgado, V.; Schalij, M.J.; Atsma, D.E.; Bax, J.J. & Marsan, N.A. (2017), Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy, Circulation 136(9): 873-873.
- Hiemstra, Y.L.; Debonnaire, P.; Bootsma, M.; Zwet, E.W. van; Delgado, V.; Schalij, M.J.; Atsma, D.E.; Bax, J.J. & Marsan, N.A. (2017), Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy, Circulation: Cardiovascular Imaging 10(7).
- Debonnaire, P.; Emer, J.; Hiemstra, Y.; Mertens, B.; Atsma, D.; Schalij, M.; Bax, J.; Delgado, V. & Marsan, N.A. (2017), Left atrial size and function in 242 hypertrophic cardiomyopathy patients and risk of new onset atrial fibrillation, Acta Cardiologica 72(1): 112-113.
- Debonnaire, P.; Joyce, E.; Hiemstra, Y.; Mertens, B.J.; Atsma, D.E.; Schalij, M.J.; Bax, J.J.; Delgado, V. & Marsan, N.A. (2017), Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation, Circulation: Arrhythmia and Electrophysiology 10(2).
- Treskes, R.W.; Velde, E.T. van der; Atsma, D.E. & Schalij, M.J. (2016), Redesigning healthcare: The 2.4 billion euro question? Connecting smart technology to improve outcome of patients, Netherlands Heart Journal 24(7-8): 441-446.
- den Haan MC, van Zuylen VL, Pluijmert NJ, Schutte CI, Fibbe WE, Schalij MJ, Roelofs H & Atsma DE (2016), Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?, PLoS ONE 11(4).
- Haan, M.C. den; Zuylen, V.L. van; Pluijmert, N.J.; Schutte, C.I.; Fibbe, W.E.; Schalij, M.J.; Roelofs, H. & Atsma, D.E. (2016), Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?, PLoS ONE 11(4).
- Rodrigo, S.F.; Mann, I.; Rarnshorst, J. van; Beeres, S.L.M.A.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2016), Reduction of healthcare utilization after bone marrow cell therapy for refractory angina pectoris, International Journal of Cardiology 202: 571-572.
- Mann, I.; Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Roos, A. de; Wolterbeek, R.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2015), Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life, Circulation: Cardiovascular Interventions 8(8).
- Mann, I.; Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.M.A.; Lamb, H.J.; Siebelink, H.M.; Geest, R.J. van der; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2015), Presence of myocardial scar does not prevent improvement in myocardial perfusion and left ventricular function in refractory angina patients undergoing intramyocardial bone marrow cell injection, European Heart Journal 36: 353-353.
- Zuylen, V.L. van; Haan, M.C. den; Roelofs, H.; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2015), Myocardial infarction models in NOD/Scid mice for cell therapy research: permanent ischemia vs ischemia-reperfusion, Springerplus 4.
- Groeneweg, J.A.; Bhonsale, A.; James, C.A.; Riele, A.S. te; Dooijes, D.; Tichnell, C.; Murray, B.; Wiesfeld, A.C.P.; Sawant, A.C.; Kassamali, B.; Atsma, D.E.; Volders, P.G.; Groot, N.M. de; Boer, K. de; Zimmerman, S.L.; Kamel, I.R.; Heijden, J.F. van der; Russell, S.D.; Cramer, M.J.; Tedford, R.J.; Doevendans, P.A.; Veen, T.A. van; Tandri, H.; Wilde, A.A.; Judge, D.P.; Tintelen, J.P. van; Hauer, R.N. & Calkins, H. (2015), Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members, Circulation: Cardiovascular Genetics 8(3): 437-446.
- Debonnaire, P.; Katsanos, S.; Joyce, E.; Brink, O.V.W. van den; Atsma, D.E.; Schalij, M.J.; Bax, J.J.; Delgado, V. & Marsan, N.A. (2015), QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy, Journal of Cardiovascular Electrophysiology 26(5): 547-555.
- Gyongyosi, M.; Wojakowski, W.; Lemarchand, P.; Lunde, K.; Tendera, M.; Bartunek, J.; Marban, E.; Assmus, B.; Henry, T.D.; Traverse, J.H.; Moye, L.A.; Surder, D.; Corti, R.; Huikuri, H.; Miettinen, J.; Wohrle, J.; Obradovic, S.; Roncalli, J.; Malliaras, K.; Pokushalov, E.; Romanov, A.; Kastrup, J.; Bergmann, M.W.; Atsma, D.E.; Diederichsen, A.; Edes, I.; Benedek, I.; Benedek, T.; Pejkov, H.; Nyolczas, N.; Pavo, N.; Bergler-Klein, J.; Pavo, I.J.; Sylven, C.; Berti, S.; Navarese, E.P.; Maurer, G. & ACCRUE Investigators (2015), Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in Patients With Acute Myocardial Infarction Based on Individual Patient Data, Circulation Research 116(8): 1346-1360.
- Bhonsale, A.; Groeneweg, J.A.; James, C.A.; Dooijes, D.; Tichnell, C.; Jongbloed, J.D.H.; Murray, B.; Riele, A.S.J.M.T.; Berg, M.P. van den; Bikker, H.; Atsma, D.E.; Groot, N.M. de; Houweling, A.C.; Heijden, J.F. van der; Russell, S.D.; Doevendans, P.A.; Veen, T.A. van; Tandri, H.; Wilde, A.A.; Judge, D.P.; Tintelen, J.P. van; Calkins, H. & Hauer, R.N. (2015), Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers, European Heart Journal 36(14): 847-855.
- Zuylen, V.L. van; Haan, M.C. den; Geutskens, S.B.; Roelofs, H.; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2015), Post-myocardial Infarct Inflammation and the Potential Role of Cell Therapy, Cardiovascular Drugs and Therapy 29(1): 59-73.
- Birket, M.J.; Ribeiro, M.C.; Kosmidis, G.; Ward, D.; Leitoguinho, A.R.; Pol, V. van de; Dambrot, C.; Devalla, H.D.; Davis, R.P.; Mastroberardino, P.G.; Atsma, D.E.; Passier, R. & Mummery, C.L. (2015), Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function, Cell Reports.
- Zhang, M.; D'Aniello, C.; Verkerk, A.O.; Wrobel, E.; Frank, S.; Oostwaard, D.W.; Piccini, I.; Freund, C.; Rao, J.; Seebohm, G.; Atsma, D.E.; Schulze-Bahr, E.; Mummery, C.L.; Greber, B. & Bellin, M. (2014), Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue, Proceedings of the National Academy of Sciences 111(50): E5383-E5392.
- Ramkisoensing, A.A. & Atsma, D.E. (2014), Image-guided intramyocardial cell injection: putting a puzzle piece in the right place, Netherlands Heart Journal 22(11): 491-492.
- Dambrot, C.; Buermans, H.P.J.; Varga, E.; Kosmidis, G.; Langenberg, K.; Casini, S.; Elliott, D.A.; Dinnyes, A.; Atsma, D.E.; Mummery, C.L.; Braam, S.R. & Davis, R.P. (2014), Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones, Experimental Cell Research 327(2): 297-306.
- Mann, I.; Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Roos, A. de; Bax, J.J.; Fibbe, W.E.; Schalij, M.J. & Atsma, D.E. (2014), Repeated intramyocardial cell injection again improves perfusion, anginal complaints and quality of life in previously responding cell therapy patients, European Heart Journal 35: 644-645.
- Dambrot, C.; Braam, S.R.; Tertoolen, L.G.J.; Birket, M.; Atsma, D.E. & Mummery, C.L. (2014), Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes.
- Rodrigo, S.F.; Ramshorst, J. van; Mann, I.; Leong, D.P.; Cannegieter, S.C.; Younis, I. al; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2014), Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia, International Journal of Cardiology 175(3): 539-544.
- Pijnappels, D.A.; Schalij, M.J.; Atsma, D.E. & Vries, A.A.F. de (2014), Cardiac Anisotropy, Regeneration, and Rhythm, Circulation Research 115(4): E6-E7.
- Atsma D.E. (20 June 2014). Hart 3.0: stimulatie tot regeneratie. Medicine, Leiden. Leiden. [inaugural address].
- Ramkisoensing, A.A.; Vries, A.A.F. de; Atsma, D.E.; Schalij, M.J. & Pijnappels, D.A. (2014), Interaction between myofibroblasts and stem cells in the fibrotic heart: balancing between deterioration and regeneration, Cardiovascular Research 102(2): 224-231.
- Mann, I.; Rodrigo, S.; Ramshorst, J. van; Beeres, S.; Roos, A. de; Bax, J.; Fibbe, W.E.; Schalij, M. & Atsma, D. (2014), PREVIOUSLY RESPONDING NO-OPTION PATIENTS WITH RESIDUAL OR RECURRENT REFRACTORY ANGINA PECTORIS AND DOCUMENTED ISCHEMIA BENEFIT FROM REPEAT INTRAMYOCARDIAL INJECTION OF AUTOLOGOUS BONE MARROW CELLS, Journal of the American College of Cardiology 63(12): A1595-A1595.
- Ramshorst, J. van; Beeres, S.L.M.A.; Rodrigo, S.F.; Dibbets-Schneider, P.; Scholte, A.J.; Fibbe, W.E.; Zwaginga, J.J.; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2014), Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemia, International Journal of Cardiovascular Imaging 30(3): 583-589.
- Debonnaire, P.; Thijssen, J.; Leong, D.P.; Joyce, E.; Katsanos, S.; Hoogslag, G.E.; Schalij, M.J.; Atsma, D.E.; Bax, J.J.; Delgado, V. & Marsan, N.A. (2014), Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients, International Journal of Cardiovascular Imaging 30(3): 549-558.
- Debonnaire, P.; Katsanos, S.; Joyce, E.; Brink, O. van den; Atsma, D.; Schalij, M.; Bax, J.; Delgado, V. & Marsan, N.A. (2013), Baseline ECG in hypertrophic cardiomyopathy patients relates to sustained ventricular tachyarrhythmia and sudden cardiac death: value of QTc duration and QRS fragmentation., Acta Cardiologica 68(5): 533-534.
- Rodrigo, S.F.; Ramshorst, J. van; Hoogslag, G.E.; Boden, H.; Velders, M.A.; Cannegieter, S.C.; Roelofs, H.; Younis, I. al; Dibbets-Schneider, P.; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2013), Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up, Journal of Cardiovascular Translational Research 6(5): 816-825.
- Groeneweg, J.A.; Zwaag, P.A. van der; Nordkamp, L.R.A.O.; Bikker, H.; Jongbloed, J.D.H.; Jongbloed, R.; Wiesfeld, A.C.P.; Cox, M.G.P.J.; Heijden, J.F. van der; Atsma, D.E.; Boer, K. de; Doevendans, P.A.; Vink, A.; Veen, T.A.B. van; Dooijes, D.; Berg, M.P. van den; Wilde, A.A.M.; Tintelen, J.P. van & Hauer, R.N. (2013), Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers, American Journal of Cardiology 112(8): 1197-1206.
- Ramshorst, J. van; Rodrigo, S.F.; Beeres, S.L.M.A.; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2013), Long term effects of intramyocardial bone marrow cell injection on anginal symptoms and quality of life in patients with chronic myocardial ischemia, International Journal of Cardiology 168(3): 3031-3032.
- Debonnaire, P.; Katsanos, S.; Joyce, E.; Brinck, O.V.W. van den; Atsma, D.E.; Schalij, M.J.; Bax, J.J.; Delgado, V. & Marsan, N.A. (2013), QTc duration and QRS fragmentation on baseline ECG relate to sustained ventricular tachyarrhythmia and sudden cardiac death in hypertrophic cardiomyopathy, European Heart Journal 34: 527-527.
- Velde, E.T. van der; Atsma, D.E.; Foeken, H.; Witteman, T.A. & Hoekstra, W.H.G.J. (2013), Remote monitoring of patients with implanted devices: data exchange and integration, European Journal of Preventive Cardiology 20: 8-12.
- Askar, S.F.A.; Ramkisoensing, A.A.; Atsma, D.E.; Schalij, M.J.; Vries, A.A.F. de & Pijnappels, D.A. (2013), Engraftment Patterns of Human Adult Mesenchymal Stem Cells Expose Electrotonic and Paracrine Proarrhythmic Mechanisms in Myocardial Cell Cultures, Circulation: Arrhythmia and Electrophysiology 6(2): 380-391.
- Dambrot, C.; Pas, S. van de; Zijl, L. van; Brandl, B.; Wang, J.W.; Schalij, M.J.; Hoeben, R.C.; Atsma, D.E.; Mikkers, H.M.; Mummery, C.L. & Freund, C. (2013), Polycistronic lentivirus induced pluripotent stem cells from skin biopsies after long term storage, blood outgrowth endothelial cells and cells from milk teeth, Differentiation 85(3): 101-109.
- Askar, S.F.A.; Bingen, B.O.; Schalij, M.J.; Swildens, J.; Atsma, D.E.; Schutte, C.I.; Vries, A.A.F. de; Zeppenfeld, K.; Ypey, D.L. & Pijnappels, D.A. (2013), Similar arrhythmicity in hypertrophic and fibrotic cardiac cultures caused by distinct substrate-specific mechanisms., Cardiovascular Research 97(1): 171-81.
- Ramkisoensing, A.A.; Vries, A.A.F. de; Schalij, M.J.; Atsma, D.E. & Pijnappels, D.A. (2012), Brief Report: Misinterpretation of Coculture Differentiation Experiments by Unintended Labeling of Cardiomyocytes Through Secondary Transduction: Delusions and Solutions, STEM CELLS 30(12): 2830-2834.
- Yiu, K.H.; Atsma, D.E.; Delgado, V.; Ng, A.C.T.; Witkowski, T.G.; Ewe, S.H.; Auger, D.; Holman, E.R.; Mil, A.M. van; Breuning, M.H.; Tse, H.F.; Bax, J.J.; Schalij, M.J. & Marsan, N.A. (2012), Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers., PLoS ONE 7(5): e36115.
- Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Younis, I. al; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2012), Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison, American Heart Journal 164(5): 771-778.
- Dambrot, A.; Braam, S.R.; Freund, C.M.A.H.; Pas, S. van de; Oostwaard, D.W.V.; Atsma, D.E. & Mummery, C.L. (2012), Human induced pluripotent stem cells as in vitro model for hypertrophic cardiomyopathy, European Heart Journal 33: 22-22.
- Haan, M.C. den; Grauss, R.W.; Smits, A.M.; Winter, E.M.; Tuyn, J. van; Pijnappels, D.A.; Steendijk, P.; Gittenberger-De Groot, A.C.; Laarse, A. van der; Fibbe, W.E.; Vries, A.A.F. de; Schalij, M.J.; Doevendans, P.A.; Goumans, M.J. & Atsma, D.E. (2012), Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts, Journal of Cellular and Molecular Medicine 16(7): 1508-1521.
- Ramkisoensing, A.A.; Pijnappels, D.A.; Swildens, J.; Goumans, M.J.; Fibbe, W.E.; Schalij, M.J.; Vries, A.A.F. de & Atsma, D.E. (2012), Gap Junctional Coupling with Cardiomyocytes is Necessary but Not Sufficient for Cardiomyogenic Differentiation of Cocultured Human Mesenchymal Stem Cells, STEM CELLS 30(6): 1236-1245.
- Yiu, K.H.; Atsma, D.E.; Delgado, V.; Ng, A.C.T.; Witkowski, T.G.; Ewe, S.H.; Auger, D.; Holman, E.R.; Mil, A.M. van; Breuning, M.H.; Tse, H.F.; Bax, J.J.; Schalij, M.J. & Marsan, N.A. (2012), Myocardial Structural Alteration and Systolic Dysfunction in Preclinical Hypertrophic Cardiomyopathy Mutation Carriers, PLoS ONE 7(5): -.
- Haeck, M.L.A.; Hoogslag, G.E.; Rodrigo, S.F.; Atsma, D.E.; Klautz, R.J.; Wall, E.E. van der; Schalij, M.J. & Verwey, H.F. (2012), Treatment options in end-stage heart failure: where to go from here?, Netherlands Heart Journal 20(4): 167-175.
- Rodrigo, S.; Ramshorst, J. van; Beeres, S.; Younis, I. al; Dibbets-Schneider, P.; Fibbe, W.; Zwaginga, J.J.; Wall, E. van der; Schalij, M.; Bax, J. & Atsma, D. (2012), INTRAMYOCARDIAL INJECTION OF BONE MARROW DERIVED, EX VIVO EXPANDED, MESENCHYMAL STEM CELLS IN ACUTE MYOCARDIAL INFARCTION PATIENTS IS SAFE AND IMPROVES MYOCARDIAL PERFUSION AT 3 YEARS FOLLOW UP, Journal of the American College of Cardiology 59(13): E478-E478.
- Ramkisoensing, A.A.; Pijnappels, D.A.; Swildens, J.; Goumans, M.J.; Schalij, M.J.; Vries, A.A.F. de & Atsma, D.E. (2012), Gap junctional coupling with cardiomyocytes is essential for cardiomyogenic differentiation of fetal human mesenchymal stem cells, Cardiovascular Research 93: S15-S15.
- Askar, S.F.; Bingen, B.O.; Swildens, J.; Ypey, D.L.; Laarse, A. van der; Atsma, D.E.; Zeppenfeld, K.; Schalij, M.J.; Vries, A.A. de & Pijnappels, D.A. (2012), Connexin43 silencing in myofibroblasts prevents arrhythmias in myocardial cultures: role of maximal diastolic potential, Cardiovascular Research 93(3): 434-444.
- Askar, S.F.; Bingen, B.O.; Swildens, J.; Ypey, D.L.; Laarse, A. van der; Atsma, D.E.; Zeppenfeld, K.; Schalij, M.J.; Vries, A.A. de & Pijnappels, D.A. (2012), Connexin43 silencing in myofibroblasts prevents arrhythmias in myocardial cultures: role of maximal diastolic potential., Cardiovascular Research 93(3): 434-44.
- Boden, H.; Hoeven, B.L. van der; Liem, S.S.; Atary, J.Z.; Cannegieter, S.C.; Atsma, D.E.; Bootsma, M.; Jukema, J.W.; Zeppenfeld, K.; Oemrawsingh, P.V.; Wall, E.E. van der & Schalij, M.J. (2012), Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.
- Boden, H.; Hoeven, B.L. van der; Liem, S.S.; Atary, J.Z.; Cannegieter, S.C.; Atsma, D.E.; Bootsma, M.; Jukema, J.W.; Zeppenfeld, K.; Oemrawsingh, P.V.; Wall, E.E. van der & Schalij, M.J. (2012), Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.
- Bax, N.A.M.; Pijnappels, D.A.; Oorschot, A.A.M. van; Winter, E.M.; Vries, A.A.F. de; Tuyn, J. van; Braun, J.; Maas, S.; Schalij, M.J.; Atsma, D.E.; Goumans, M.J. & Gittenberger-de Groot, A.C. (2011), Epithelial-to-mesenchymal transformation alters electrical conductivity of human epicardial cells, Journal of Cellular and Molecular Medicine 15(12): 2675-2683.
- Rodrigo, S.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Wall, E.E. van der; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2011), Efficacy of Intramyocardial Injection of Bone Marrow Cells in Chronic Myocardial Disease is Influenced by Anatomical Location of Injection Site, Circulation 124(21): -.
- Ramkisoensing, A.A.; Pijnappels, D.A.; Swildens, J.; Schalij, M.J.; Vries, A.A. de & Atsma, D.E. (2011), Induction of Cardiomyogenic Differentiation in Human Mesenchymal Stem Cells is Mediated by Gap Junctional Coupling with Cultured Rat Cardiomyocytes, Circulation 124(21): -.
- Rodrigo, S.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Stokkel, M.; Fibbe, W.E.; Zwaginga, J.J.; Wall, E.E. van der; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2011), Intramyocardial Bone Marrow Cell Injection in Patients with Chronic Myocardial Ischemia: Results Long Term Follow-Up, Circulation 124(21): -.
- Rodrigo, S.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Wall, E.E. van der; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2011), Intramyocardial Injection of Bone Marrow Mononuclear Cells in Patients with Chronic Myocardial Ischemia: an Intra-Patient Comparison, Circulation 124(21): -.
- Rodrigo, S.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Wall, E.E. van der; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2011), The Influence of Patient Characteristics on Treatment Outcome of Bone Marrow Cell Injection in Patients with Chronic Myocardial Ischemia, Circulation 124(21): -.
- Haeck, M.L.A.; Hoogslag, G.E.; Rodrigo, S.F.; Atsma, D.E.; Klautz, R.J.; Wall, E.E. van der; Schalij, M.J. & Verwey, H.F. (2011), Treatment options in end-stage heart failure: where to go from here?, Netherlands Heart Journal.
- Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.M.A.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2011), Cell Therapy for the Treatment of Chronic Ischemic Heart Disease, Current Pharmaceutical Design 17(30): 3308-3327.
- Haan, M.C. den; Grauss, R.W.; Smits, A.M.; Winter, E.M.; Tuyn, J. van; Pijnappels, D.A.; Steendijk, P.; Gittenberger-De Groot, A.C.; Laarse, A. van der; Fibbe, W.E.; Vries, A.A.F. de; Schalij, M.J.; Doevendans, P.A.; Goumans, M.J. & Atsma, D.E. (2011), Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischemic mouse hearts.
- Cox, M.G.P.J.; Zwaag, P.A. van der; Werf, C. van der; Smagt, J.J. van der; Noorman, M.; Bhuiyan, Z.A.; Wiesfeld, A.C.P.; Volders, P.G.A.; Langen, I.M. van; Atsma, D.E.; Dooijes, D.; Wijngaard, A. van den; Houweling, A.C.; Jongbloed, J.D.H.; Jordaens, L.; Cramer, M.J.; Doevendans, P.A.; Bakker, J.M.T. de; Wilde, A.A.M.; Tintelen, J.P. van & Hauer, R.N.W. (2011), Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study, Circulation 123(23): 2690-U87.
- Christiaans, I.; Birnie, E.; Bonsel, G.J.; Mannens, M.M.A.M.; Michels, M.; Majoor-Krakauer, D.; Dooijes, D.; Tintelen, J.P. van; Berg, M.P. van den; Volders, P.G.A.; Arens, Y.H.; Wijngaard, A. van den; Atsma, D.E.; Helderman-van den Enden, A.T.J.M.; Houweling, A.C.; Boer, K. de; Smagt, J.J. van der; Hauer, R.N.W.; Marcelis, C.L.M.; Timmermans, J.; Langen, I.M. van & Wilde, A.A.M. (2011), Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy, European Heart Journal 32(9): 1161-1170.
- Ramshorst, J. van; Rodrigo, S.F.; Schalij, M.J.; Beeres, S.L.M.A.; Bax, J.J. & Atsma, D.E. (2011), Bone Marrow Cell Injection for Chronic Myocardial Ischemia: The Past and the Future., Journal of Cardiovascular Translational Research.
- Ramshorst, J. van; Antoni, M.L.; Beeres, S.L.M.A.; Roes, S.D.; Delgado, V.; Rodrigo, S.F.; Roos, A. de; Holman, E.R.; Fibbe, W.E.; Lamb, H.J.; Zwaginga, J.J.; Boersma, E.; Wall, E.E. van der; Schalij, M.J.; Atsma, D.E. & Bax, J.J. (2011), Intramyocardial Bone Marrow-Derived Mononuclear Cell Injection for Chronic Myocardial Ischemia: the Effect on Diastolic Function., Circulation: Cardiovascular Imaging.
- Swildens, J.; Vries, A.A.F. de; Li, Z.; Umar, S.; Atsma, D.E.; Schalij, M.J. & Laarse, A. van der (2010), Integrin Stimulation Favors Uptake of Macromolecules by Cardiomyocytes In Vitro, Cellular Physiology and Biochemistry 26(6): 999-1010.
- Umar, S.; Steendijk, P.; Ypey, D.L.; Atsma, D.E.; Wall, E.E. van der; Schalij, M.J. & Laarse, A. van der (2010), Novel Approaches to Treat Experimental Pulmonary Arterial Hypertension: A Review, Journal of Biomedicine and Biotechnology.
- Cox, M.G.P.J.; Bhuiyan, Z.A.; Wiesfeld, A.C.; Volders, P.G.A.; Atsma, D.E.; Dooijes, D.; Houweling, A.C.; Tintelen, J.P. van; Wilde, A.A.M. & Hauer, R.N.W. (2010), Comprehensive DNA analysis in Dutch ARVD/C patients, European Heart Journal 31: 444-445.
- Atary, J.Z.; Visser, M. de; Dijk, R. van den; Bosch, J.; Liem, S.S.; Antoni, M.L.; Bootsma, M.; Viergever, E.P.; Kirchhof, C.J.; Padmos, I.; Sedney, M.I.; Exel, H.J. van; Verwey, H.F.; Atsma, D.E.; Wall, E.E. van der; Jukema, J.W. & Schalij, M.J. (2010), Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice, Netherlands Heart Journal 18(9): 408-415.
- Smits, A.M.; Ramkisoensing, A.A.; Atsma, D.E. & Goumans, M.J. (2010), Young at heart. An update on cardiac regeneration, Minerva Medica 101(4): 255-269.
- Atary, J.Z.; Hoeven, B.L. van der; Liem, S.S.; Jukema, J.W.; Bom, J.G. van der; Atsma, D.E.; Bootsma, M.; Zeppenfeld, K.; Wall, E.E. van der & Schalij, M.J. (2010), Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study), American Journal of Cardiology 106(1): 4-12.
- Cox, M.G.P.J.; Smagt, J.J. van der; Noorman, M.; Wiesfeld, A.C.; Volders, P.G.A.; Langen, I.M. van; Atsma, D.E.; Dooijes, D.; Houweling, A.C.; Loh, P.; Jordaens, L.; Arens, Y.; Cramer, M.J.; Doevendans, P.A.; Tintelen, P. van; Wilde, A.A.M. & Hauer, R.N.W. (2010), Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task Force Criteria Impact of New Task Force Criteria, Circulation: Arrhythmia and Electrophysiology 3(2): 126-133.
- Christiaans, I.; Birnie, E.; Langen, I.M. van; Spaendonck-Zwarts, K.Y. van; Tintelen, J.P. van; Berg, M.P. van den; Atsma, D.E.; Helderman-van den Enden, A.T.J.M.; Pinto, Y.M.; Hermans-van Ast, J.F.; Bonsel, G.J. & Wilde, A.A.M. (2010), The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening, European Heart Journal 31(7): 842-848.
- Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani E, Wagenaar GTM, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE & van der Laarse A (2009), Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension, AJP - Heart and Circulatory Physiology 297(5): H1606H1616.
- Winter EM, van Oorschot AA, Hogers B, van der Graaf LM, Doevendans PA, Poelmann RE, Atsma DE, Gittenberger-de Groot AC & Goumans MJ (2009), A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells., Circulation: Heart Failure 2(6): 643-53.
- Winter, E.M.; Oorschot, A.A.M. van; Hogers, B.; Graaf, L.M. van der; Doevendans, P.A.; Poelmann, R.E.; Atsma, D.E.; Gittenberger-de Groot, A.C. & Goumans, M.J. (2009), A New Direction for Cardiac Regeneration Therapy Application of Synergistically Acting Epicardium-Derived Cells and Cardiomyocyte Progenitor Cells, Circulation: Heart Failure 2(6): 643-653.
- Cox MGPJ, van der Smagt JJ, Wilde AAM, Wiesfeld ACP, Atsma DE, Nelen MR, Rodriguez LM, Loh P, Cramer MJ, Doevendans PA, van Tintelen JP, de Bakker JMT & Hauer RNW (2009), New ECG Criteria in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy, Circulation: Arrhythmia and Electrophysiology 2(5): 524-530.
- Hassan, A.K.M.; Liem, S.S.; Kley, F. van der; Bergheanu, S.C.; Wolterbeek, R.; Bosch, J.; Bootsma, M.; Zeppenfeld, K.; Laarse, A. van der; Atsma, D.E.; Jukerna, J.W. & Schalij, M.J. (2009), In-Ambulance Abciximab Administration in STEMI Patients Prior to Primary PCI is Associated with Smaller Infarct Size, Improved LV Function and Lower Incidence of Heart Failure: Results from the Leiden MISSION! Acute Myocardial Infarction Treatment Optimization Program, Catheterization and Cardiovascular Interventions 74(2): 335-343.
- van Ramshorst J, Mollema SA, Delgado V, van der Wall EE, Schalij MJ, Atsma DE & Bax JJ (2009), Relation of Immediate Decrease in Ventricular Septal Strain After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy to Long-Term Reduction in Left Ventricular Outflow Tract Pressure Gradient, American Journal of Cardiology 103(11): 1592-1597.
- van Ramshorst J, Bax JJ, Beeres SLMA, Dibbets-Schneider P, Roes SD, Stokkel MPM, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ & Atsma DE (2009), Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia A Randomized Controlled Trial, Journal of the American Medical Association 301(19): 1997-2004.
- Hassan AKM, Bergheanu SC, Hasan-Ali H, Liem SS, van der Laarse A, Wolterbeek R, Atsma DE, Schalij MJ & Jukema JW (2009), Usefulness of Peak Troponin-T to Predict Infarct Size and Long-Term Outcome in Patients With First Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention, American Journal of Cardiology 103(6): 779-784.
- van Ramshorst J, Atsma DE, Beeres SLMA, Mollema SA, Marsan NA, Holman ER, van der Wall EE, Schalij MJ & Bax JJ (2009), Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain, Heart 95(2): 119-124.
- Umar S, van der Valk E, Schalij MJ, van der Wall EE, Atsma DE & van der Laarse A (2009), Integrin stimulation-induced hypertrophy in neonatal rat cardiomyocytes is NO-dependent, Molecular and Cellular Biochemistry 320(1-2): 75-84.
- Pijnappels DA, Schalij MJ & Atsma DE (2009), Response to the Letter by Rose et al, Circulation Research 104(1): E8E8.
- Ye, D.; Kraaijeveld, A.O.; Grauss, R.W.; Willems, S.M.; Vark-van der Zee, L.C. van; Jager, S.C.A. de; Jauhiainen, M.; Kuivenhoven, J.A.; Dallinga-Thie, G.M.; Atsma, D.E.; Hogendoorn, P.C.W.; Biessen, E.A.L.; Berkel, T.J.C. van; Jukema, J.W. & Eck, M. van (2008), Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes, Journal of Internal Medicine 264(6).
- Winter, E.M.; Grauss, R.W.; Atsma, D.E.; Hogers, B.; Poelmann, R.E.; Geest, R.J. van der; Tschope, C.; Schalij, M.J.; Groot, A.C.G.D. & Steendijk, P. (2008), Left ventricular function in the post-infarct failing mouse heart by magnetic resonance imaging and conductance catheter: a comparative analysis, Acta Physiologica 194(2).
- Hessel MHM, Michielsen ECHJ, Atsma DE, Schalij MJ, van der Valk EJM, Bax WH, Hermens WT, van Dieijen-Visser MP & van der Laarse A (2008), Release kinetics of intact and degraded troponin I and T after irreversible cell damage, Experimental and Molecular Pathology 85(2).
- de Jager SCA, Kraaijeveld AO, Grauss RW, de Jager W, Liem SS, van der Hoeven BL, Prakken BJ, Putter H, van Berkel TJC, Atsma DE, Schalij MJ, Jukema JW & Biessen EAL (2008), CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events, Journal of Molecular and Cellular Cardiology 45(3).
- Beeres SLMA, Atsma DE, van Ramshorst J, Schalij MJ & Bax JJ (2008), Cell therapy for ischaemic heart disease, Heart 94(9).
- Umar S, Bax JJ, Klok M, van Bommel RJ, Hessel MHM, den Adel B, Bleeker GB, Hennernan MM, Atsma DE, van der Wall EE, Schalij MJ & van der Laarse A (2008), Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy, European Journal of Heart Failure 10(9).
- Pijnappels DA, Schalij MJ, Ramkisoensing AA, van Tuyn J, de Vries AAF, van der Laarse A, Ypey DL & Atsma DE (2008), Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures, Circulation Research 103(2).
- Beeres SLMA, Lamb HJ, Roes SD, Holman ER, Kaandorp TAM, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ, Bax JJ & Atsma DE (2008), Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia, Journal of Magnetic Resonance Imaging 27(5).
- Brinke EAT, Klautz RJ, Tulner SA, Engbers FH, Verwey HF, Atsma DE, Schalij MJ, van der Wall EE, Bax JJ, Putter H, Dion RA & Steendijk P (2008), Haemodynamics and left ventricular function in heart failure patients: Comparison of awake versus intra-operative conditions, European Journal of Heart Failure 10(5).
- Hessel MHM, Atsma DE, van der Valk EJM, Bax WH, Schalij MJ & van der Laarse A (2008), Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation, Pfl�gers Archiv European Journal of Physiology 455(6).
- van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, van der Wall EE & Schalij MJ (2008), Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome - Results from the MISSION! Intervention study, Journal of the American College of Cardiology 51(6).
- Rijken DC, Nobel EHD, Jie AFH, Atsma DE, Schalij MJ & Nieuwenhuizen W (2008), Development of a new test for the global fibrinolytic capacity in whole blood, Journal of Thrombosis and Haemostasis 6(1).
- Atsma DE, Fibbe WE & Rabelink TJ (2007), Opportunities and challenges for mesenchymal stem cell-mediated heart repair, Current Opinion in Lipidology 18(6).
- van Tuyn J, Pijnappels DA, de Vries AAF, de Vries I, Dijke IVDVV, Knaan-Shanzer S, van der Laarse A, Schalij MJ & Atsma DE (2007), Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene, FASEB Journal 21(12).
- Grauss, R.W.; Winter, E.M.; Tuyn, J. van; Pijnappels, D.A.; Steijn, R.V.; Hogers, B.; Geest, R.J. van der; Vries, A.A.F. de; Steendijk, P.; Laarse, A. van der; Groot, A.C.G.D.; Schalij, M.J. & Atsma, D.E. (2007), Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction, AJP - Heart and Circulatory Physiology 293(4).
- Hessel MHM, Bleeker GB, Bax JJ, Hennernan MM, den Adel B, Klok M, Schalij MJ, Atsma DE & van der Laarse A (2007), Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels, European Journal of Heart Failure 9(10).
- Pijnappels DA, van Tuyn J, de Vries AAF, Grauss RW, van der Laarse A, Ypey DL, Atsma DE & Schalij MJ (2007), Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts, Circulation 116(18).
- Beeres SLMA, Bax JJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2007), Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction, American Journal of Cardiology 100(7).
- Winter, E.M.; Grauss, R.W.; Hogers, B.; Tuyn, J. van; Geest, R. van der; Lie-Venema, H.; Steijn, R.V.; Maas, S.; DeRuiter, M.C.; Vries, A.A.F. de; Steendijk, P.; Doevendans, P.A.; Laarse, A. van der; Poelmann, R.E.; Schalij, M.J.; Atsma, D.E. & Gittenberger-de Groot, A.C. (2007), Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart, Circulation 116(8).
- O'Neill WW, Martin JL, Dixon SR, Bartorelli AL, Trabattoni D, Oemrawsingh PV, Atsma DE, Chang M, Marquardt W, Oh JK, Krucoff MW, Gibbons RJ & Spears JR (2007), Acute myocardial infarction with hyperoxemic therapy (AMIHOT) - A prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention, Journal of the American College of Cardiology 50(5).
- Beeres SLMA, Zeppenfeld K, Bax JJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Atsma DE & Schalij MJ (2007), Etectrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease, Heart Rhythm 4(3).
- Beeres SLMA, Bengel FM, Bartunek J, Atsma DE, Hill JM, Vanderheyden M, Penicka M, Schalij MJ, Wijns W & Bax JJ (2007), Role of imaging in cardiac stem cell therapy, Journal of the American College of Cardiology 49(11).
- Tuyn, J. van; Atsma, D.E.; Winter, E.M.; Velde-Van Dijke, I. van der; Pijnappels, D.A.; Bax, N.A.M.; Knaan-Shanzer, S.; Gittenberger-de Groot, A.C.; Poelmann, R.E.; Laarse, A. van der; Wall, E.E. van der; Schalij, M.J. & Vries, A.A.F. de (2007), Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro, STEM CELLS 25(2).
- Beeres SLMA, Bax JJ, Zeppenfeld K, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2007), Feasibility of trans-endocardial cell transplantation in chronic ischaemia, Heart 93(1).
- Liem SS, van der Hoeven BL, Oemrawsingh PV, Bax JJ, van der Bom JG, Bosch J, Viergever EP, van Rees C, Padmos I, Sedney MI, van Exel HJ, Verwey HF, Atsma DE, van der Velde ET, Jukema JW, van der Wall EE & Schalij MJ (2007), MISSION! Optimization of acute and chronic care for patients with acute myocardial infarction, American Heart Journal 153(1).
- Umar S, Hessel M, Steendijk P, Bax W, Schutte C, Schalij M, van der Wall E, Atsma D & van der Laarse A (2007), Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension, Pathology - Research and Practice 203(12).
- Schuijf JD, Wijns W, Jukema W, Atsma DE, de Roos A, Lamb HJ, Stokkel MPM, Dibbets-Schneider P, Decramer I, De Bondt P, van der Wall EE, Vanhoenacker PK & Bax JJ (2006), Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging, Journal of the American College of Cardiology 48(12).
- Schuijf JD, Wijns W, Jukema JW, DeCramer I, Atsma DE, de Roos A, Stokkel MPM, Dibbets-Schneider P, van der Wall EE & Bax JJ (2006), A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT, Journal of Nuclear Medicine 47(11).
- Pijnappels DA, Schalij MJ, van Tuyn J, Ypey DL, de Vries AAF, van der Wall EE, van der Laarse A & Atsma DE (2006), Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling, Cardiovascular Research 72(2).
- Beeres SLMA, Bax JJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2006), Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: Twelve-month follow-up results, American Heart Journal 152(4).
- van der Hoeven BL, Liem SS, Oemrawsingh PV, Dijkstra J, Jukema JW, Putter H, Atsma DE, van der Wall EE, Bax JJ, Reiber JC & Schalij MJ (2006), Role of calcified spots detected by intravascular ultrasound in patients with ST-segment elevation acute myocardial infarction, American Journal of Cardiology 98(3).
- Atsma DE, Beeres SLMA & Schalij MJ (2006), Mesenchymal stem cells repair conduction block - Reply, Journal of the American College of Cardiology 48(1).
- Beeres SLMA, Bax JJ, Kaandorp TAM, Zeppenfeld K, Lamb HJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ & Atsma DE (2006), Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia, American Journal of Cardiology 97(9).
- Beeres SLMA, Bax JJ, Dibbets P, Stokkel MPM, Zeppenfeld K, Fibbe WE, van der Wall EE, Schalij MJ & Atsma DE (2006), Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia, Journal of Nuclear Medicine 47(4).
- Beeres SLMA, Atsma DE, van der Laarse A, Pijnappels DA, van Tuyn J, Fibbe WE, de Vries AAF, Ypey DL, van der Wall EE & Schalij MJ (2005), Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures, Journal of the American College of Cardiology 46(10).
- Monraats PS, Pires NMM, Agema WRP, Zwinderman AH, Schepers A, de Maat MPM, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, Quax PHA, van Vlijmen BJM, Atsma DE, van der Laarse A, van der Wall EE & Jukema JW (2005), Genetic inflammatory factors predict restenosis after percutaneous coronary interventions, Circulation 112(16).
- Beeres SLMA, Oemrawsingh PV, Warda HM, Bechan R, Atsma DE, Jukema JW, van der Wall EE & Schalij MJ (2005), Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty, Catheterization and Cardiovascular Interventions 65(4).
- van Tuyn J, Knaan-Shanzer S, van de Watering MJM, de Graaf M, van der Laarse A, Schalij MJ, van der Wall EE, de Vries AAF & Atsma DE (2005), Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin, Cardiovascular Research 67(2).
- Warda HM, Bax JJ, Bosch JG, Atsma DE, Jukema JW, van der Wall EE, van der Laarse A, Schalij MJ & Oemrawsingh PV (2005), Effect of intracoronary aqueous oxygen on left ventricular remodeling after anterior wall ST-elevation acute myocardial infarction, American Journal of Cardiology 96(1).
- Kerkhoffs JL, Atsma DE, Oemrawsingh PV, Eikenboom J & Van der Meer FJM (2004), Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild haemophilia A, Thrombosis and Haemostasis 92(2).
- Agema WRP, Monraats PS, Zwinderman AH, de Winter RJ, Tio RA, Doevendans PAFM, Waltenberger J, de Maat MPM, Frants RR, Atsma DE, van der Laarse A, van der Wall EE & Jukema JW (2004), Current PTCA practice and clinical outcomes in the Netherlands: the real world in the pre-drug-eluting stent era, European Heart Journal 25(13).
- Bax JJ, Atsma DE, Lamb HJ, Rebergen SA, Bootsma M, Voogd PJ, Somer S, Schalij MJ, de Roos A & van der Wall EE (2002), Noninvasive and invasive evaluation of noncompaction cardiomyopathy, Journal of Cardiovascular Magnetic Resonance 4(3).
- Bavelaar-Croon CDL, Wahba FFMF, Van Hecke MV, Atsma DE, Stokkel MPM, Pauwels EKJ & Van der Wall EE (2001), Perfusion and functional abnormalities outside the septal region in patients with left bundle branch block assessed with gated SPECT, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 45(1).
- Bavelaar-Croon CDL, America YGCJ, Atsma DE, Dibbets-Schneider P, Zwinderman AH, Stokkel MPM, Pauwels EKJ & van der Wall EE (2001), Comparison of left ventricular function at rest and post-stress in patients with myocardial infarction: Evaluation with gated SPECT, Journal of Nuclear Cardiology 8(1).
- Bavelaar-Croon CDL, Atsma DE, Van der Wall EE, Dibbets-Schneider P, Zwinderman AH & Pauwels EKJ (2001), The additive value of gated SPET myocardial perfusion imaging in patients with known and suspected coronary artery disease, Nuclear Medicine Communications 22(1).
- Atsma DE, Bavelaar-Croon CDL, Germano G, Dibbets-Schneider P, van Eck-Smit BLF, Pauwels EKJ & van der Wall EE (2000), Good correlation between gated single photon emission computed myocardial tomography and contrast ventriculography in the assessment of global and regional left ventricular function, International Journal of Cardiac Imaging 16(6).
- Bavelaar-Croon CDL, Kayser HWM, van der Wall EE, de Roos A, Dibbets-Schneider P, Pauwels EKJ, Germano G & Atsma DE (2000), Left ventricular function: Correlation of quantitative gated SPECT and MR imaging over a wide range of values, Radiology 217(2).
- bestuurslid
- Voorzitter Raad van Toezicht
- bestuurslid
- Reviewer verschillende vakbladen, Spreker patiëntbijeenkomsten
- Lid